![](/img/cover-not-exists.png)
The histone deacetylase inhibitor panobinostat demonstrates marked synergy with conventional chemotherapeutic agents in human ovarian cancer cell lines
Daniel R. Budman, Julia Tai, Anthony Calabro, Veena JohnVolume:
29
Language:
english
Pages:
6
DOI:
10.1007/s10637-010-9467-6
Date:
December, 2011
File:
PDF, 150 KB
english, 2011